NOTE:     The following Minutes are provided for informational purposes only.

If you would like to obtain an official copy of these Minutes, please contact the

State Board of Pharmacy at 614/466-4143 for instructions and fee.

 

 

 

Minutes Of The Meeting

Ohio State Board of Pharmacy

Columbus, Ohio

May 1, 2, 3, 2000

 

MONDAY, may 1, 2000

 

12:07 p.m.      ROLL CALL

 

The State Board of Pharmacy convened in Room 1948, Vern Riffe Center for Government and the Arts, 77 South High Street, Columbus, Ohio with the following members present:

 

Robert B. Cavendish, R.Ph. (President); Diane C. Adelman, R.Ph. (Vice-President); Ann D. Abele, R.Ph.; Suzanne R. Eastman, R.Ph.; Robert P. Giacalone, R.Ph.; Lawrence J. Kost, R.Ph.; and Nicholas R. Repke, Public Member.

 

Also present were William T. Winsley, Executive Director; Timothy Benedict, Assistant Executive Director; David Rowland, Legal Affairs Administrator; and Sally Ann Steuk, Assistant Attorney General.

12:11 p.m.

Ms. Abele moved that the Board go into Executive Session for the purpose of the investigation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code and for the purpose of conferring with an attorney for the Board regarding pending or imminent court action pursuant to Section 121.22(G)(3) of the Revised Code.The motion was seconded by Mr. Repke and a roll call vote was conducted by President Cavendish as follows: Abele-Yes, Adelman-Yes, Eastman-Yes, Giacalone-Yes, Kost-Yes, and Repke-Yes.

12:52 p.m.

Mr. Littlejohn arrived and joined the Executive Session in progress.

12:59 p.m.

RES. 2000-154   The Executive Session ended and the Board meeting resumed in Public Session.Ms. Abele moved that the Board refuse the settlement offer made in the matters of Martin Barron and the Medicine Shoppe Pharmacy and that the hearing be held in June as scheduled.The motion was seconded by Ms. Eastman and approved by the Board (Aye-7/Nay-0).

 

RES. 2000-155   Mr. Winsley announced that the Settlement Agreement with Suellen Ogden, R.Ph. has been signed and is effective as follows:

 

(1)     Records of the Board of Pharmacy indicate that Suellen Ogden was originally licensed in the state of Ohio on April 27, 1995, pursuant to examination, and on November 23, 1999, her license was summarily suspended in accordance with Section 3719.121(C) of the Ohio Revised Code.Records further indicate that during the relevant time periods stated herein, Suellen Ogden was the Responsible Pharmacist at Chesterfield Pharmacy, 1799 E. 12th St., Cleveland, Ohio pursuant to Sections 4729.27 and 4729.55 of the Ohio Revised Code and Rule 4729-5-11 of the Ohio Administrative Code.

 

(2)     Suellen Ogden, as the Responsible Pharmacist did, on or about January 1, 1996, and dates previous, fail to keep a record of drugs purchased, possessed, and dispensed, to wit: a Compliance Agent for the Board was advised on July 21 and July 22, 1997, that all records of drugs dated before January 1, 1996, were purged from the computer and not kept at Chesterfield Pharmacy; the Compliance Agentís inspection confirmed this fact.Such conduct is in violation of Section 3719.07 of the Ohio Revised Code and Rule 4729-5-28(F) of the Ohio Administrative Code.

 

(3)     Suellen Ogden did, from November 16, 1995, through February 26, 1996, dispense drugs pursuant to improper prescriptions and kept them in the pharmacy, to wit: Suellen Ogden failed to either record the date of the dispensing and/or manually record her initials on original prescriptions numbered 23112401, 23112402, 23112403, 23112404, and 23118119.Such conduct is in violation of Section 3719.07 of the Ohio Revised Code and Rule 4729-5-27(A) of the Ohio Administrative Code.

 

(4)     Suellen Ogden, as the Responsible Pharmacist did, on or about July 21 and July 22, 1997, fail to provide effective and approved controls and procedures to guard against theft and diversion of dangerous drugs, to wit: a computer terminal which allowed access to the records of dangerous drugs and an after-hours drop box containing dangerous drugs at Chesterfield Pharmacy were located outside the confines of the physical barricade, allowing access by unlicensed persons other than health professionals.Such conduct is in violation of Rules 4729-9-05 and 4729-9-11(A)(2)(f) of the Ohio Administrative Code.

 

(5)     Suellen Ogden, as the Responsible Pharmacist did, on or about July 21 and July 22, 1997, fail to properly execute controlled substance order forms, i.e. D.E.A. 222 forms, to wit: when drugs were received at Chesterfield Pharmacy pursuant to the following D.E.A. 222 forms, the forms were not completed as to the amount of controlled substances received nor the date received: 961201879, 961201880, 961201906, 962251283, 962251305, 970778598, and 970778599.Such conduct is in violation of Section 3719.07 of the Ohio Revised Code and Section 1305.09 of the Code of Federal Regulations.

 

(6)     Suellen Ogden, as the Responsible Pharmacist did, on or about July 21 and July 22, 1997, and dates preceding, continuously fail to perform prospective drug utilization review and patient counseling, to wit: when dispensing medications to a patient pursuant to prescriptions, Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy failed to review the original prescription and/or refill information for over-utilization, incorrect drug dosage and duration of drug treatment, and misuse; and pharmacists failed to offer patient counseling.Such conduct is in violation of Rules 4729-5-20 and 4729-5-22 of the Ohio Administrative Code.

 

(7)     Suellen Ogden, as the Responsible Pharmacist did, from January 12, 1996, through June 29, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #1 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23115644

Hydromet Syrup

240ml

1/12/96

23115648

hydrocodone 5mg/APAP 500mg

  60

1/12/96

23115644

Hydromet Syrup

240ml

1/17/96

23115648

hydrocodone 5mg/APAP 500mg

  60

1/18/96

23115644

Hydromet Syrup

240ml

1/22/96

23115648

hydrocodone 5mg/APAP 500mg

  60

1/24/96

23115648

hydrocodone 5mg/APAP 500mg

  60

1/30/96

23117003

hydrocodone 5mg/APAP 500mg

  60

2/6/96

23117006

Hydromet Syrup

240ml

2/6/96

23117006

Hydromet Syrup

240ml

2/10/96

23117003

hydrocodone 5mg/APAP 500mg

  60

2/13/96

23117006

Hydromet Syrup

240ml

2/15/96

23117003

hydrocodone 5mg/APAP 500mg

  60

2/19/96

23117003

hydrocodone 5mg/APAP 500mg

  60

2/24/96

23118328

hydrocodone 5mg/APAP 500mg

  60

2/28/96

23118330

Hydromet Syrup

240ml

2/28/96

23118330

Hydromet Syrup

240ml

3/4/96

23118328

hydrocodone 5mg/APAP 500mg

  60

3/5/96

23118330

Hydromet Syrup

240ml

3/9/96

23118328

hydrocodone 5mg/APAP 500mg

  60

3/11/96

23118330

Hydromet Syrup

240ml

3/14/96

23118328

hydrocodone 5mg/APAP 500mg

  60

3/18/96

23119990

hydrocodone 5mg/APAP 500mg

  60

3/27/96

23119991

Hydromet Syrup

240ml

3/27/96

23119991

Hydromet Syrup

240ml

3/30/96

23119990

hydrocodone 5mg/APAP 500mg

  60

4/2/96

23119991

Hydromet Syrup

240ml

4/3/96

23119990

hydrocodone 5mg/APAP 500mg

  60

4/8/96

23119990

hydrocodone 5mg/APAP 500mg

  60

4/15/96

23121655

Hydromet Syrup

240ml

4/25/96

23121655

Hydromet Syrup

240ml

4/29/96

23121655

Hydromet Syrup

240ml

5/4/96

23123584

Hydromet Syrup

240ml

5/30/96

23123585

hydrocodone 5mg/APAP 500mg

  60

5/30/96

23123584

Hydromet Syrup

240ml

6/4/96

23123585

hydrocodone 5mg/APAP 500mg

  60

6/7/96

23123584

Hydromet Syrup

240ml

6/10/96

23123585

hydrocodone 5mg/APAP 500mg

  60

6/13/96

23123585

hydrocodone 5mg/APAP 500mg

  60

6/24/96

23125375

hydrocodone 5mg/APAP 500mg

  60

6/29/96

23125376

Hydromet Syrup

240ml

6/29/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(8)     Suellen Ogden, as the Responsible Pharmacist did, from July 3, 1996, through September 28, 1996, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #1 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23125376

Hydromet Syrup

240ml

7/3/96

23125375

hydrocodone 5mg/APAP 500mg

  60

7/5/96

23125376

Hydromet Syrup

240ml

7/9/96

23125375

hydrocodone 5mg/APAP 500mg

  60

7/18/96

23125375

hydrocodone 5mg/APAP 500mg

  60

7/25/96

23127024

Hydromet Syrup

240ml

7/31/96

23127026

hydrocodone 5mg/APAP 500mg

  60

7/31/96

23127024

Hydromet Syrup

240ml

8/5/96

23127024

Hydromet Syrup

240ml

8/9/96

23127026

hydrocodone 5mg/APAP 500mg

  60

8/13/96

23127999

hydrocodone 5mg/APAP 500mg

  60

8/21/96

23128001

Hydromet Syrup

240ml

8/21/96

23128001

Hydromet Syrup

240ml

8/26/96

23128001

Hydromet Syrup

240ml

8/30/96

23127999

hydrocodone 5mg/APAP 500mg

  60

9/3/96

23129363

Hydromet Syrup

240ml

9/18/96

23129363

Hydromet Syrup

240ml

9/23/96

23129363

Hydromet Syrup

240ml

9/28/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(9)     Suellen Ogden, as the Responsible Pharmacist did, from July 31, 1996, through September 18, 1996, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #1 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23127023

Roxicet

120

7/31/96

23127998

Roxicet

120

8/21/96

23129364

Roxicet

120

9/18/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(10)   Suellen Ogden, as the Responsible Pharmacist did, from October 14, 1995, through June 26, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #2 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23110600

Hydromet Syrup

240ml

10/14/95

23110601

hydrocodone 5mg/APAP 500mg

100

10/14/95

23110601

hydrocodone 5mg/APAP 500mg

100

11/6/95

23112203

Hydromet Syrup

240ml

11/13/95

23110601

hydrocodone 5mg/APAP 500mg

100

11/15/95

23112203

Hydromet Syrup

240ml

11/16/95

23110601

hydrocodone 5mg/APAP 500mg

100

11/25/95

23110601

hydrocodone 5mg/APAP 500mg

100

12/5/95

23113937

Hydromet Syrup

240ml

12/13/95

23113939

hydrocodone 5mg/APAP 500mg

  84

12/13/95

23113937

Hydromet Syrup

240ml

12/16/95

23113939

hydrocodone 5mg/APAP 500mg

  84

12/21/95

23115287

Hydromet Syrup

240ml

1/8/96

23115289

hydrocodone 5mg/APAP 500mg

  84

1/8/96

23115287

Hydromet Syrup

240ml

1/11/96

23115289

hydrocodone 5mg/APAP 500mg

  84

1/20/96

23116699

Hydromet Syrup

240ml

2/1/96

23116713

hydrocodone 5mg/APAP 500mg

  84

2/1/96

23116699

Hydromet Syrup

240ml

2/5/96

23116713

hydrocodone 5mg/APAP 500mg

  84

2/12/96

23118339

hydrocodone 5mg/APAP 500mg

  84

2/28/96

23118340

Hydromet Syrup

240ml

2/28/96

23118340

Hydromet Syrup

240ml

3/4/96

23118339

hydrocodone 5mg/APAP 500mg

  84

3/11/96

23119248

Hydromet Syrup

240ml

3/14/96

23119258

hydrocodone 5mg/APAP 500mg

125

3/14/96

23119248

Hydromet Syrup

240ml

3/18/96

23119258

hydrocodone 5mg/APAP 500mg

125

4/3/96

23119258

hydrocodone 5mg/APAP 500mg

125

4/22/96

23121647

Hydromet Syrup

240ml

4/25/96

23121647

Hydromet Syrup

240ml

4/29/96

23119258

hydrocodone 5mg/APAP 500mg

125

5/8/96

23119258

hydrocodone 5mg/APAP 500mg

  40

5/25/96

23123589

Hydromet Syrup

240ml

5/30/96

23123749

Hydromet Syrup

240ml

6/3/96

23123749

Hydromet Syrup

240ml

6/7/96

23125144

hydrocodone 5mg/APAP 500mg

  84

6/26/96

23125145

Hydromet Syrup

240ml

6/26/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(11)   Suellen Ogden, as the Responsible Pharmacist did, from December 13, 1995, through June 26, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #2 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23113938

Roxicet

  90

12/13/95

23115288

Roxicet

  90

1/8/96

23116714

Roxicet

  90

2/1/96

23118338

Roxicet

  90

2/28/96

23119259

Roxicet

125

3/14/96

23121675

Roxicet

125

4/25/96

23123590

Roxicet

  90

5/30/96

23123750

Roxicet

  90

6/3/96

23125146

Roxicet

  90

6/26/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(12)   Suellen Ogden, as the Responsible Pharmacist did, from July 1, 1996, through October 10, 1996, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #2 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23125145

Hydromet Syrup

240ml

7/1/96

23125144

hydrocodone 5mg/APAP 500mg

  84

7/9/96

23125144

hydrocodone 5mg/APAP 500mg

  84

7/22/96

23126525

Hydromet Syrup

240ml

7/23/96

23126525

Hydromet Syrup

240ml

7/29/96

23125144

hydrocodone 5mg/APAP 500mg

  84

8/3/96

23127713

hydrocodone 5mg/APAP 500mg

  60

8/14/96

23127713

hydrocodone 5mg/APAP 500mg

  60

8/20/96

23128348

Hydromet Syrup

240ml

8/28/96

23128349

hydrocodone 5mg/APAP 500mg

  84

8/28/96

23128348

Hydromet Syrup

240ml

9/3/96

23128349

hydrocodone 5mg/APAP 500mg

  84

9/9/96

23128349

hydrocodone 5mg/APAP 500mg

  84

9/21/96

23128349

hydrocodone 5mg/APAP 500mg

  84

10/10/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(13)   Suellen Ogden, as the Responsible Pharmacist did, from July 23, 1996, through August 21, 1996, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #2 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23126526

Roxicet

90

7/23/96

23127712

Roxicet

60

8/14/96

23128003

Roxicet

60

8/21/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(14)   Suellen Ogden, as the Responsible Pharmacist did, from February 2, 1996, through June 28, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #3 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23116765

alprazolam 1mg

112

2/28/96

23119729

alprazolam 1mg

112

3/22/96

23119729

alprazolam 1mg

112

4/17/96

23122555

alprazolam 1mg

112

5/10/96

23122555

alprazolam 1mg

112

6/4/96

23125306

alprazolam 1mg

112

6/28/96

23116765

alprazolam 1mg

112

2/2/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(15)   Suellen Ogden, as the Responsible Pharmacist did, from March 22, 1996, through June 28, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #3 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23119726

diazepam 10mg

168

3/22/96

23119726

diazepam 10mg

168

4/17/96

23119726

diazepam 10mg

168

5/10/96

23119726

diazepam 10mg

168

6/4/96

23119726

diazepam 10mg

168

6/28/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(16)   Suellen Ogden, as the Responsible Pharmacist did, from July 24, 1996, through June 5, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #3 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23125306

alprazolam 1mg

112

7/24/96

23127783

alprazolam 1mg

112

8/16/96

23127783

alprazolam 1mg

112

9/12/96

23130509

alprazolam 1mg

112

10/8/96

23130509

alprazolam 1mg

112

11/8/96

23133144

alprazolam 1mg

112

11/29/96

23133144

alprazolam 1mg

112

12/23/96

23133144

alprazolam 1mg

112

1/31/97

305243

alprazolam 1mg

120

5/9/97

305243

alprazolam 1mg

120

6/5/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(17)   Suellen Ogden, as the Responsible Pharmacist did, from July 24, 1996, through June 5, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #3 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23119726

diazepam 10mg

168

7/24/96

23127786

diazepam 10mg

168

8/16/96

23127786

diazepam 10mg

168

9/12/96

23127786

diazepam 10mg

168

10/8/96

23127786

diazepam 10mg

168

11/4/96

23127786

diazepam 10mg

168

11/29/96

23127786

diazepam 10mg

168

12/23/96

300841

diazepam 10mg

168

1/31/97

301671

diazepam 10mg

168

2/19/97

301671

diazepam 10mg

168

3/16/97

301671

diazepam 10mg

168

4/16/97

301671

diazepam 10mg

168

5/9/97

301671

diazepam 10mg

168

6/5/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(18)   Suellen Ogden, as the Responsible Pharmacist did, from July 12, 1995, through June 12, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #4 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23105227

phentermine 37.5mg

14

7/12/95

23106097

phentermine 37.5mg

14

7/26/95

23106858

phentermine 37.5mg

14

8/9/95

23107624

phentermine 37.5mg

14

8/23/95

23108336

phentermine 37.5mg

14

9/6/95

23115472

phentermine 37.5mg

14

1/10/96

23116293

Adipex-P

14

1/24/96

23117099

phentermine 37.5mg

14

2/7/96

23117853

phentermine 37.5mg

14

2/21/96

23118700

phentermine 37.5mg

14

3/6/96

23119585

phentermine 37.5mg

14

3/20/96

23120463

phentermine 37.5mg

14

4/3/96

23122821

phentermine 37.5mg

14

5/15/96

23124332

phentermine 37.5mg

14

6/12/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(19)   Suellen Ogden, as the Responsible Pharmacist did, from November 14, 1996, through July 8, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding fifty times the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #4 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23131680

hydrocodone 5mg/APAP 500mg

60

11/14/96

23132417

Hydromet Syrup

240ml

11/14/96

23132417

Hydromet Syrup

240ml

11/20/96

23132417

Hydromet Syrup

240ml

11/25/96

23133099

hydrocodone 5mg/APAP 500mg

60

11/27/96

23133101

hydrocodone/homatropine syrup

240ml

11/30/96

23133099

hydrocodone 5mg/APAP 500mg

60

12/7/96

23133101

hydrocodone/homatropine syrup

240ml

12/7/96

23133704

hydrocodone/homatropine syrup

240ml

12/11/96

23133099

hydrocodone 5mg/APAP 500mg

60

12/16/96

23133704

Hydromet Syrup

240ml

12/24/96

23133099

hydrocodone 5mg/APAP 500mg

60

12/26/96

23133099

hydrocodone 5mg/APAP 500mg

60

1/4/97

23133099

hydrocodone 5mg/APAP 500mg

60

1/14/97

300282

hydrocodone 5mg/APAP 500mg

60

1/22/97

300282

hydrocodone 5mg/APAP 500mg

60

1/31/97

300283

Hydromet Syrup

240ml

2/5/97

300282

hydrocodone 5mg/APAP 500mg

60

2/10/97

300283

Hydromet Syrup

240ml

2/10/97

300282

hydrocodone 5mg/APAP 500mg

60

2/20/97

300282

hydrocodone 5mg/APAP 500mg

60

3/3/97

302301

Hydromet Syrup

240ml

3/5/97

300282

hydrocodone 5mg/APAP 500mg

60

3/12/97

302301

Hydromet Syrup

240ml

3/12/97

303143

hydrocodone 5mg/APAP 500mg

60

3/24/97

303143

hydrocodone 5mg/APAP 500mg

60

4/5/97

303143

hydrocodone 5mg/APAP 500mg

60

4/16/97

304060

Hydrocodone compound

240ml

4/16/97

303143

hydrocodone 5mg/APAP 500mg

60

4/26/97

304060

hydrocodone compound

240ml

4/26/97

303143

hydrocodone 5mg/APAP 500mg

60

5/5/97

303143

hydrocodone 5mg/APAP 500mg

60

5/14/97

305948

hydrocodone 5mg/APAP 500mg

60

5/24/97

305948

hydrocodone 5mg/APAP 500mg

60

6/3/97

305948

hydrocodone 5mg/APAP 500mg

60

6/13/97

305948

hydrocodone 5mg/APAP 500mg

60

6/21/97

305948

hydrocodone 5mg/APAP 500mg

60

6/30/97

305948

hydrocodone 5mg/APAP 500mg

60

7/8/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(20)   Suellen Ogden, as the Responsible Pharmacist did, from July 10, 1996, through July 22, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #4 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23125861

phentermine 37.5mg

14

7/10/96

23127256

phentermine 37.5mg

14

8/7/96

23131678

phentermine 37.5mg

14

10/30/96

23132414

phentermine 37.5mg

14

11/14/96

23133100

phentermine 37.5mg

14

11/27/96

23133703

phentermine 37.5mg

14

12/11/96

23134402

phentermine 37.5mg

14

12/24/96

303468

phentermine 37.5mg

14

4/2/97

304055

phentermine 37.5mg

14

4/16/97

305478

phentermine 37.5mg

14

5/14/97

306191

phentermine 37.5mg

14

5/30/97

306722

phentermine 37.5mg

14

6/10/97

307299

phentermine 37.5mg

14

6/24/97

307855

phentermine 37.5mg

14

7/8/97

308392

phentermine 37.5mg

14

7/22/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(21)   Suellen Ogden, as the Responsible Pharmacist did, from December 18, 1995, through June 3, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #5 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23113453

diazepam 10mg

56

12/18/95

23113453

diazepam 10mg

56

12/27/95

23113453

diazepam 10mg

56

1/23/96

23113453

diazepam 10mg

56

2/8/96

23117970

diazepam 10mg

56

2/23/96

23117970

diazepam 10mg

56

3/5/96

23113453

diazepam 10mg

56

3/16/96

23117970

diazepam 10mg

56

3/25/96

23117970

diazepam 10mg

56

4/8/96

23121468

diazepam 10mg

84

4/23/96

23121468

diazepam 10mg

84

5/23/96

23123730

diazepam 10mg

84

6/3/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(22)   Suellen Ogden, as the Responsible Pharmacist did, from December 14, 1995, through June 20, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #5 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23112912

Klonopin 2mg

  35

12/14/95

23112912

Klonopin 2mg

  35

12/23/95

23114819

Klonopin 2mg

  42

1/13/96

23114819

Klonopin 2mg

  42

1/23/96

23114819

Klonopin 2mg

  42

2/1/96

23114819

Klonopin 2mg

  42

2/8/96

23117335

Klonopin 2mg

  42

2/12/96

23117969

Klonopin 2mg

112

2/23/96

23117969

Klonopin 2mg

112

3/5/96

23118704

Klonopin 2mg

100

3/6/96

23117969

Klonopin 2mg

112

3/16/96

23118704

Klonopin 2mg

100

3/25/96

23122341

Klonopin 2mg

100

5/7/96

23118704

Klonopin 2mg

100

5/23/96

23118704

Klonopin 2mg

100

6/6/96

23118704

Klonopin 2mg

100

6/20/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(23)   Suellen Ogden, as the Responsible Pharmacist did, from December 27, 1995, through June 3, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #5 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23113454

flurazepam 30mg

14

12/27/95

23116233

flurazepam 30mg

14

1/23/96

23117334

flurazepam 30mg

14

2/12/96

23116233

flurazepam 30mg

14

2/23/96

23117334

flurazepam 30mg

14

3/5/96

23118702

flurazepam 30mg

14

3/6/96

23118702

flurazepam 30mg

14

3/16/96

23120777

flurazepam 30mg

14

4/9/96

23122344

flurazepam 30mg

14

5/7/96

23123733

flurazepam 30mg

14

6/3/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(24)   Suellen Ogden, as the Responsible Pharmacist did, on or about July 1, 1996, knowingly sell or offer to sell a controlled substance in an amount less than the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold 84 unit doses of diazepam 10mg, pursuant to prescription number 23123730, to Patient #5 without a legitimate medical purpose.Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(25)   Suellen Ogden, as the Responsible Pharmacist did, on or about July 1, 1996, knowingly sell or offer to sell a controlled substance in an amount less than the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold 100 unit doses of Klonopin 2mg, pursuant to prescription number 23118704, to Patient #5 without a legitimate medical purpose.Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(26)   Suellen Ogden, as the Responsible Pharmacist did, from November 25, 1995, through June 24, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #6 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23109697

hydrocodone 5mg/APAP 500mg

84

11/25/95

23112889

Hydromet Syrup

240ml

11/25/95

23112889

Hydromet Syrup

240ml

12/4/95

23112890

hydrocodone 5mg/APAP 500mg

84

12/4/95

23112890

hydrocodone 5mg/APAP 500mg

84

12/15/95

23112890

hydrocodone 5mg/APAP 500mg

84

12/26/95

23112890

hydrocodone 5mg/APAP 500mg

84

1/5/96

23115188

hydrocodone 5mg/APAP 500mg

84

1/19/96

23115188

hydrocodone 5mg/APAP 500mg

84

1/31/96

23116668

Hydromet Syrup

240ml

1/31/96

23115188

hydrocodone 5mg/APAP 500mg

84

2/13/96

23116668

Hydromet Syrup

240ml

2/13/96

23115188

hydrocodone 5mg/APAP 500mg

84

2/27/96

23118360

Hydromet Syrup

240ml

2/28/96

23118360

Hydromet Syrup

240ml

3/12/96

23119069

hydrocodone 5mg/APAP 500mg

84

3/12/96

23119069

hydrocodone 5mg/APAP 500mg

84

3/25/96

23119069

hydrocodone 5mg/APAP 500mg

84

4/8/96

23120803

Hydromet Syrup

240ml

4/9/96

23119069

hydrocodone 5mg/APAP 500mg

84

4/20/96

23120803

Hydromet Syrup

240ml

4/20/96

23121838

hydrocodone 5mg/APAP 500mg

90

4/27/96

23121838

hydrocodone 5mg/APAP 500mg

90

5/8/96

23121838

hydrocodone 5mg/APAP 500mg

90

5/18/96

23121838

hydrocodone 5mg/APAP 500mg

90

5/31/96

23124162

Hydromet Syrup

240ml

6/8/96

23124163

hydrocodone 5mg/APAP 500mg

84

6/11/96

23124162

Hydromet Syrup

240ml

6/17/96

23124163

hydrocodone 5mg/APAP 500mg

84

6/24/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(27)   Suellen Ogden, as the Responsible Pharmacist did, from July 8, 1996, through July 22, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding fifty times the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #6 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23124163

hydrocodone 5mg/APAP 500mg

84

7/8/96

23124163

hydrocodone 5mg/APAP 500mg

84

7/20/96

23124162

Hydromet Syrup

240ml

7/26/96

23126552

hydrocodone 5mg/APAP 500mg

84

8/1/96

23124162

Hydromet Syrup

240ml

8/8/96

23126552

hydrocodone 5mg/APAP 500mg

84

8/12/96

23127583

Hydromet Syrup

240ml

8/12/96

23126552

hydrocodone 5mg/APAP 500mg

84

8/22/96

23127583

Hydromet Syrup

240ml

8/22/96

23126552

hydrocodone 5mg/APAP 500mg

84

8/31/96

23127946

hydrocodone 5mg/APAP 500mg

125

9/5/96

23127946

hydrocodone 5mg/APAP 500mg

43

9/5/96

23127583

Hydromet Syrup

240ml

9/7/96

23129956

hydrocodone 5mg/APAP 500mg

84

9/27/96

23127583

Hydromet Syrup

240ml

10/11/96

23129956

hydrocodone 5mg/APAP 500mg

84

10/11/96

23129956

hydrocodone 5mg/APAP 500mg

84

10/19/96

23131415

Hydromet Syrup

240ml

10/24/96

23129956

hydrocodone 5mg/APAP 500mg

84

10/28/96

23131421

hydrocodone 5mg/APAP 500mg

84

11/6/96

23131415

Hydromet Syrup

240ml

11/9/96

23131421

hydrocodone 5mg/APAP 500mg

84

11/15/96

23131415

Hydromet Syrup

240ml

11/26/96

23131421

hydrocodone 5mg/APAP 500mg

84

11/26/96

23131421

hydrocodone 5mg/APAP 500mg

84

12/6/96

23131415

Hydromet Syrup

240ml

12/17/96

23134024

hydrocodone 5mg/APAP 500mg

84

12/17/96

23134025

Hydromet Syrup

240ml

12/24/96

23134024

hydrocodone 5mg/APAP 500mg

84

12/28/96

23134024

hydrocodone 5mg/APAP 500mg

84

1/7/97

23134025

Hydromet Syrup

240ml

1/7/97

23134024

hydrocodone 5mg/APAP 500mg

84

1/17/97

300736

hydrocodone 5mg/APAP 500mg

84

1/29/97

23134025

Hydromet Syrup

240ml

1/31/97

300736

hydrocodone 5mg/APAP 500mg 0

84

2/11/97

23134025

Hydromet Syrup

240ml

2/12/97

301605

Hydromet Syrup

240ml

2/18/97

300736

hydrocodone 5mg/APAP 500mg

84

2/20/97

300736

hydrocodone 5mg/APAP 500mg

84

3/1/97

301605

Hydromet Syrup

240ml

3/5/97

302605

hydrocodone 5mg/APAP 500mg

90

3/10/97

301605

Hydromet Syrup

240ml

3/18/97

302605

hydrocodone 5mg/APAP 500mg

90

3/19/97

301605

Hydromet Syrup

240ml

3/27/97

302605

hydrocodone 5mg/APAP 500mg

90

3/28/97

302605

hydrocodone 5mg/APAP 500mg

90

4/7/97

303974

hydrocodone 5mg/APAP 500mg

90

4/15/97

303975

hydrocodone compound

240ml

4/15/97

303975

hydrocodone compound

240ml

4/22/97

303974

hydrocodone 5mg/APAP 500mg

90

4/25/97

303974

hydrocodone 5mg/APAP 500mg

90

5/3/97

303975

hydrocodone compound

240ml

5/3/97

303975

hydrocodone compound

240ml

5/12/97

305346

hydrocodone 5mg/APAP 500mg

90

5/12/97

305346

hydrocodone 5mg/APAP 500mg

90

5/21/97

305784

hydrocodone compound

240ml

5/21/97

305346

hydrocodone 5mg/APAP 500mg

90

5/31/97

305784

hydrocodone compound

240ml

5/31/97

305784

hydrocodone compound

240ml

6/5/97

306511

hydrocodone 5mg/APAP 500mg

90

6/10/97

305784

hydrocodone compound

240ml

6/19/97

307320

hydrocodone compound

240ml

6/24/97

307321

hydrocodone 5mg/APAP 500mg

90

6/24/97

307320

hydrocodone compound

240ml

7/15/97

307320

hydrocodone compound

240ml

7/22/97

308402

hydrocodone 5mg/APAP 500mg

90

7/22/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(28)   Suellen Ogden, as the Responsible Pharmacist did, from December 31, 1996, through July 21, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding fifty times the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #7 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23133915

Vicodin

90

12/31/96

23133467

Hydromet Syrup

240ml

1/2/97

23133915

Vicodin

90

1/15/97

23133467

Hydromet Syrup

240ml

1/30/97

23133915

Vicodin

90

1/30/97

23133915

Vicodin

90

2/15/97

302075

Hycodan Syrup

240ml

2/27/97

302074

Vicodin

90

3/3/97

302074

Vicodin

90

3/17/97

302075

Hycodan Syrup

240ml

3/17/97

302074

Vicodin

90

3/31/97

302075

Hycodan Syrup

240ml

3/31/97

302074

Vicodin

90

4/14/97

303958

Hycodan Syrup

240ml

4/14/97

302074

Vicodin

90

4/28/97

303958

Hycodan Syrup

240ml

4/28/97

303958

Hycodan Syrup

240ml

5/12/97

305319

Vicodin

90

5/12/97

305319

Vicodin

90

5/27/97

306034

Hycodan Syrup

240ml

5/27/97

305319

Vicodin

90

6/9/97

306034

Hycodan Syrup

240ml

6/9/97

305319

Vicodin

90

6/23/97

306034

Hycodan Syrup

240ml

6/23/97

305319

Vicodin

90

7/7/97

308377

Vicodin

90

7/21/97

308379

Hycodan Syrup

240ml

7/21/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(29)   Suellen Ogden, as the Responsible Pharmacist did, from April 9, 1997, through July 23, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #8 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

303827

alprazolam 2mg

100

04/09/97

303827

alprazolam 2mg

100

04/29/97

303827

alprazolam 2mg

100

05/19/97

303827

alprazolam 2mg

100

06/11/97

303827

alprazolam 2mg

100

07/02/97

303827

alprazolam 2mg

100

07/23/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(30)   Suellen Ogden, as the Responsible Pharmacist did, from March 4, 1997, through May 19, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding the bulk amount, but in an amount less than five times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #8 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

302195

diazepam 10mg

90

03/04/97

302195

diazepam 10mg

90

03/19/97

302195

diazepam 10mg

90

04/03/97

302195

diazepam 10mg

90

04/19/97

302195

diazepam 10mg

90

05/05/97

302195

diazepam 10mg

90

05/19/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(31)   Suellen Ogden, as the Responsible Pharmacist did, from March 4, 1997, through May 19, 1997, knowingly sell or offer to sell a controlled substance in an amount equal to or exceeding the bulk amount, but in an amount less than five times bulk when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #8 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

302199

oxazepam 30mg

30

03/04/97

302199

oxazepam 30mg

30

03/19/97

303825

oxazepam 30mg

30

04/09/97

303825

oxazepam 30mg

30

05/19/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(32)   Suellen Ogden, as the Responsible Pharmacist did, from May 3, 1995, through May 16, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #9 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23101144

Ionamin 30mg

14

5/3/95

23102693

Ionamin 30mg

14

5/30/95

23103667

Ionamin 30mg

14

6/14/95

23103971

Ionamin 30mg

14

6/20/95

23105136

Ionamin 30mg

14

7/11/95

23105984

Ionamin 30mg

14

7/25/95

23106780

Ionamin 30mg

14

8/8/95

23112253

Ionamin 30mg

14

11/14/95

23113121

Ionamin 30mg

14

11/29/95

23113717

Ionamin 30mg

14

12/9/95

23114997

Ionamin 30mg

14

1/3/96

23115947

Ionamin 30mg

14

1/17/96

23116522

Ionamin 30mg

14

1/30/96

23117508

Ionamin 30mg

14

2/14/96

23118194

Ionamin 30mg

14

2/27/96

23119154

Ionamin 30mg

14

3/13/96

23119887

Ionamin 30mg

14

3/26/96

23120892

Ionamin 30mg

14

4/10/96

23122897

Ionamin 30mg

14

5/16/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(33)   Suellen Ogden, as the Responsible Pharmacist did, from August 9, 1995, through April 29, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #9 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23106898

Pondimin 20mg

42

8/9/95

23108181

Pondimin 20mg

42

9/2/95

23109101

Pondimin 20mg

42

9/19/95

23110245

Pondimin 20mg

42

10/6/95

23110788

Pondimin 20mg

42

10/17/95

23111811

Pondimin 20mg

42

11/4/95

23114575

Pondimin 20mg

42

12/23/95

23115700

Pondimin 20mg

42

1/15/96

23116677

Pondimin 20mg

42

1/31/96

23118091

Pondimin 20mg

42

2/24/96

23119753

Pondimin 20mg

42

3/22/96

23120671

Pondimin 20mg

42

4/5/96

23121932

Pondimin 20mg

42

4/29/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(34)   Suellen Ogden, as the Responsible Pharmacist did, on or about July 5, 1996, knowingly sell or offer to sell a controlled substance in an amount less than the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold 14 unit doses of Adipex-P, pursuant to prescription number 23125634, to Patient #9 without a legitimate medical purpose.Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(35)   Suellen Ogden, as the Responsible Pharmacist did, from August 16, 1996, through September 4, 1996, knowingly sell or offer to sell a controlled substance in an amount less than the bulk amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #9 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23127831

Pondimin 20mg

42

8/16/96

23128189

Pondimin 20mg

42

8/24/96

23128552

Pondimin 20mg

42

9/4/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(36)   Suellen Ogden, as the Responsible Pharmacist did, from October 17, 1995, through March 12, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #10 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23110826

Roxiprin

125

10/17/95

23111579

Roxiprin

125

10/31/95

23112140

Roxiprin

125

11/13/95

23112948

Endodan

125

11/27/95

23114484

Endodan

125

12/22/95

23115116

Endodan

125

1/5/96

23115116

Endodan

15

1/5/96

23115739

Endodan

125

1/15/96

23116531

Roxiprin

125

1/30/96

23117365

Roxiprin

125

2/12/96

23118146

Endodan

125

2/26/96

23119000

Roxiprin

125

3/12/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(37)   Suellen Ogden, as the Responsible Pharmacist did, from October 14, 1995, through March 16, 1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #10 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23110589

hydrocodone 5mg/APAP 500mg

  40

10/14/95

23112141

Hydromet Syrup

240ml

11/13/95

23113837

Hydromet Syrup

240ml

12/12/95

23115115

Hydromet Syrup

240ml

1/5/96

23115115

Hydromet Syrup

240ml

1/11/96

23115743

Hydromet Syrup

240ml

1/15/96

23115743

Hydromet Syrup

240ml

1/20/96

23118999

Hydromet Syrup

240ml

3/12/96

23118999

Hydromet Syrup

240ml

3/16/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(38)   Suellen Ogden, as the Responsible Pharmacist did, from February 25, 1997, through July 12, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #10 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

301925

oxycodone 4.88mg/ASA 325mg

120

2/25/97

303185

oxycodone 4.88mg/ASA 325mg

125

3/25/97

304065

oxycodone 4.88mg/ASA 325mg

125

4/16/97

305426

Roxicet

125

5/13/97

306539

oxycodone 4.88mg/ASA 325mg

125

6/6/97

308010

oxycodone 4.88mg/ASA 325mg

125

7/12/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(39)   Suellen Ogden, as the Responsible Pharmacist did, from February 25, 1997, through June 17, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #10 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

301921

Hydromet Syrup

240ml

2/25/97

301921

Hydromet Syrup

240ml

3/6/97

301921

Hydromet Syrup

240ml

3/14/97

301921

Hydromet Syrup

240ml

3/20/97

303184

hydrocodone compound

240ml

3/25/97

303184

hydrocodone compound

240ml

4/2/97

303184

hydrocodone compound

240ml

4/7/97

303184

hydrocodone compound

240ml

4/11/97

304064

hydrocodone compound

240ml

4/16/97

304064

hydrocodone compound

240ml

4/21/97

304064

hydrocodone compound

240ml

4/28/97

306538

hydrocodone compound

240ml

6/6/97

306538

hydrocodone compound

240ml

6/12/97

306538

hydrocodone compound

240ml

6/17/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(40)   Suellen Ogden, as the Responsible Pharmacist did, from December 14, 1995, through June 27,1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #11 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23113982

APAP 325mg/codeine 15mg

90

12/14/95

23113982

APAP 325mg/codeine 15mg

90

12/28/95

23113982

APAP 325mg/codeine 15mg

90

1/11/96

23113982

APAP 325mg/codeine 15mg

90

1/23/96

23113982

APAP 325mg/codeine 15mg

90

2/8/96

23113982

APAP 325mg/codeine 15mg

90

2/22/96

23118772

APAP 325mg/codeine 15mg

90

3/7/96

23118772

APAP 325mg/codeine 15mg

90

3/20/96

23118772

APAP 325mg/codeine 15mg

90

4/4/96

23118772

APAP 325mg/codeine 15mg

90

4/17/96

23118772

APAP 325mg/codeine 15mg

90

5/2/96

23118772

APAP 325mg/codeine 15mg

90

5/15/96

23123558

APAP 325mg/codeine 15mg

90

5/30/96

23123558

APAP 325mg/codeine 15mg

90

6/15/96

23123558

APAP 325mg/codeine 15mg

90

6/27/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(41)   Suellen Ogden, as the Responsible Pharmacist did, from December 14, 1995, through June 27,1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #11 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23113981

hydrocodone 5mg/APAP 500mg

90

12/14/95

23113981

hydrocodone 5mg/APAP 500mg

90

12/28/95

23115565

hydrocodone 5mg/APAP 500mg

90

1/11/96

23115565

hydrocodone 5mg/APAP 500mg

90

1/25/96

23117156

hydrocodone 5mg/APAP 500mg

90

2/8/96

23117156

hydrocodone 5mg/APAP 500mg

90

2/22/96

23118771

hydrocodone 5mg/APAP 500mg

90

3/7/96

23118771

hydrocodone 5mg/APAP 500mg

90

3/20/96

23120564

hydrocodone 5mg/APAP 500mg

90

4/4/96

23120564

hydrocodone 5mg/APAP 500mg

90

4/17/96

23122105

hydrocodone 5mg/APAP 500mg

90

5/2/96

23122105

hydrocodone 5mg/APAP 500mg

90

5/15/96

23123560

hydrocodone 5mg/APAP 500mg

90

5/30/96

23123560

hydrocodone 5mg/APAP 500mg

90

6/11/96

23125201

hydrocodone 5mg/APAP 500mg

90

6/27/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(42)   Suellen Ogden, as the Responsible Pharmacist did, from July 9, 1996, through October 17, 1996, knowingly sell or offer to sell a controlled substance in an amount exceeding the bulk amount, but in an amount less than five times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy the pharmacy sold the following controlled substances to Patient #11 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23123558

APAP 325mg/codeine 15mg

90

7/9/96

23123558

APAP 325mg/codeine 15mg

90

7/24/96

23123558

APAP 325mg/codeine 15mg

90

8/6/96

23129371

APAP 325mg/codeine 15mg

90

9/18/96

23129371

APAP 325mg/codeine 15mg

90

10/2/96

23129371

APAP 325mg/codeine 15mg

90

10/17/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(43)   Suellen Ogden, as the Responsible Pharmacist did, from July 9, 1996, through October 2, 1996, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #11 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23125201

hydrocodone 5mg/APAP 500mg

90

7/9/96

23126691

hydrocodone 5mg/APAP 500mg

90

7/25/96

23126691

hydrocodone 5mg/APAP 500mg

90

8/8/96

23128045

hydrocodone 5mg/APAP 500mg

90

8/22/96

23128045

hydrocodone 5mg/APAP 500mg

90

9/4/96

23129372

hydrocodone 5mg/APAP 500mg

90

9/18/96

23129372

hydrocodone 5mg/APAP 500mg

90

10/2/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(44)   Suellen Ogden, as the Responsible Pharmacist did, from January 5, 1996, through June 24,1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #12 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23115157

hydrocodone 5mg/APAP 500mg

60

01/05/96

23115157

hydrocodone 5mg/APAP 500mg

60

01/19/96

23115157

hydrocodone 5mg/APAP 500mg

60

02/06/96

23115157

hydrocodone 5mg/APAP 500mg

60

02/16/96

23115157

hydrocodone 5mg/APAP 500mg

60

02/27/96

23115157

hydrocodone 5mg/APAP 500mg

60

03/11/96

23119830

hydrocodone 5mg/APAP 500mg

60

03/25/96

23119830

hydrocodone 5mg/APAP 500mg

60

04/06/96

23119830

hydrocodone 5mg/APAP 500mg

60

04/17/96

23119830

hydrocodone 5mg/APAP 500mg

60

04/29/96

23119830

hydrocodone 5mg/APAP 500mg

60

05/13/96

23119830

hydrocodone 5mg/APAP 500mg

60

05/24/96

23124092

hydrocodone 5mg/APAP 500mg

60

06/07/96

23124092

hydrocodone 5mg/APAP 500mg

60

06/17/96

23124092

hydrocodone 5mg/APAP 500mg

60

06/24/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(45)   Suellen Ogden, as the Responsible Pharmacist did, from January 2, 1996, through June 28,1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #12 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23114917

Roxiprin

125

01/02/96

23116520

Roxiprin

125

01/30/96

23117986

Roxiprin

125

02/23/96

23119473

Roxiprin

125

03/19/96

23121008

Roxiprin

125

04/12/96

23122499

Roxiprin

125

05/10/96

23123807

Roxiprin

125

06/04/96

23125266

Roxiprin

125

06/28/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(46)   Suellen Ogden, as the Responsible Pharmacist did, from July 6, 1996, through December 13, 1996, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #12 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23124092

hydrocodone 5mg/APAP 500mg

60

07/06/96

23124092

hydrocodone 5mg/APAP 500mg

60

07/15/96

23124092

hydrocodone 5mg/APAP 500mg

60

08/01/96

23127790

hydrocodone 5mg/APAP 500mg

60

08/17/96

23127790

hydrocodone 5mg/APAP 500mg

60

08/28/96

23127790

hydrocodone 5mg/APAP 500mg

60

09/05/96

23127790

hydrocodone 5mg/APAP 500mg

60

09/12/96

23127790

hydrocodone 5mg/APAP 500mg

60

09/21/96

23127790

hydrocodone 5mg/APAP 500mg

60

09/30/96

23131570

hydrocodone 5mg/APAP 500mg

60

11/02/96

23131570

hydrocodone 5mg/APAP 500mg

60

11/09/96

23131570

hydrocodone 5mg/APAP 500mg

60

11/16/96

23131570

hydrocodone 5mg/APAP 500mg

60

11/25/96

23131570

hydrocodone 5mg/APAP 500mg

60

12/03/96

23131570

hydrocodone 5mg/APAP 500mg

60

12/13/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(47)   Suellen Ogden, as the Responsible Pharmacist did, from July 23, 1996, through December 17, 1996, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #12 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23126486

Roxiprin

125

07/23/96

23127789

Roxiprin

125

08/16/96

23128933

Roxiprin

125

09/10/96

23130204

Roxiprin

125

10/03/96

23131569

Roxiprin

125

10/29/96

23132829

Roxiprin

125

11/22/96

23133921

oxycodone 4.88mg/ASA 325mg

125

12/17/96

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(48)   Suellen Ogden, as the Responsible Pharmacist did, from January 15, 1996, through June 21,1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #13 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23112927

hydrocodone 5mg/APAP 500mg

60

1/15/96

23112927

hydrocodone 5mg/APAP 500mg

60

1/27/96

23112927

hydrocodone 5mg/APAP 500mg

60

2/13/96

23116440

hydrocodone 7.5mg/APAP 650mg

60

2/26/96

23116440

hydrocodone 7.5mg/APAP 650mg

60

3/15/96

23116440

hydrocodone 7.5mg/APAP 650mg

60

3/28/96

23116440

hydrocodone 7.5mg/APAP 650mg

60

4/9/96

23121075

hydrocodone 7.5mg/APAP 650mg

60

4/19/96

23121075

hydrocodone 7.5mg/APAP 650mg

60

4/29/96

23121075

hydrocodone 7.5mg/APAP 650mg

60

5/13/96

23121075

hydrocodone 7.5mg/APAP 650mg

60

5/24/96

23121075

hydrocodone 7.5mg/APAP 650mg

60

6/8/96

23121075

hydrocodone 7.5mg/APAP 650mg

60

6/21/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(49)   Suellen Ogden, as the Responsible Pharmacist did, from January 15, 1996, through June 21,1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #13 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23112924

APAP 325mg/codeine 30mg

60

1/15/96

23112924

APAP 325mg/codeine 30mg

60

1/27/96

23112924

APAP 325mg/codeine 30mg

60

2/13/96

23116442

APAP 325mg/codeine 30mg

60

2/26/96

23116442

APAP 325mg/codeine 30mg

60

3/15/96

23116442

APAP 325mg/codeine 30mg

60

3/28/96

23116442

APAP 325mg/codeine 30mg

60

4/9/96

23121076

APAP 325mg/codeine 30mg

60

4/19/96

23121076

APAP 325mg/codeine 30mg

60

4/29/96

23121076

APAP 325mg/codeine 30mg

60

5/13/96

23121076

APAP 325mg/codeine 30mg

60

5/24/96

23121076

APAP 325mg/codeine 30mg

60

6/8/96

23121076

APAP 325mg/codeine 30mg

60

6/21/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(50)   Suellen Ogden, as the Responsible Pharmacist did, from July 2, 1996, through July 2, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #13 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23125512

hydrocodone 5mg/APAP 500mg

112

7/2/96

23126563

hydrocodone 5mg/APAP 500mg

49

7/24/96

23127205

hydrocodone 5mg/APAP 500mg

42

8/7/96

23127960

hydrocodone 5mg/APAP 500mg

38

8/21/96

23128633

hydrocodone 5mg/APAP 500mg

34

9/5/96

23129321

hydrocodone 5mg/APAP 500mg

38

9/18/96

23130075

hydrocodone 5mg/APAP 500mg

35

10/1/96

23130818

hydrocodone 5mg/APAP 500mg

35

10/15/96

23131562

hydrocodone 5mg/APAP 500mg

32

10/29/96

23132297

hydrocodone 5mg/APAP 500mg

29

11/12/96

23132992

hydrocodone 5mg/APAP 500mg

26

11/26/96

23133556

hydrocodone 5mg/APAP 500mg

25

12/9/96

23134375

hydrocodone 5mg/APAP 500mg

23

12/24/96

23134945

hydrocodone 5mg/APAP 500mg

23

1/7/97

300171

hydrocodone 5mg/APAP 500mg

23

1/21/97

300171

hydrocodone 5mg/APAP 500mg

23

2/4/97

301424

hydrocodone 5mg/APAP 500mg

23

2/14/97

301424

hydrocodone 5mg/APAP 500mg

23

3/3/97

302872

hydrocodone 5mg/APAP 500mg

23

3/18/97

302872

hydrocodone 5mg/APAP 500mg

23

3/31/97

303979

hydrocodone 5mg/APAP 500mg

46

4/15/97

303979

hydrocodone 5mg/APAP 500mg

46

5/12/97

306701

hydrocodone 5mg/APAP 500mg

46

6/10/97

306701

hydrocodone 5mg/APAP 500mg

46

7/2/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(51)   Suellen Ogden, as the Responsible Pharmacist did, from July 2, 1996, through July 2, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #13 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23125514

APAP 325mg/codeine 30mg

112

7/2/96

23126565

APAP 325mg/codeine 30mg

42

7/24/96

23127207

APAP 325mg/codeine 30mg

42

8/7/96

23127959

APAP 325mg/codeine 30mg

42

8/21/96

23128632

APAP 325mg/codeine 30mg

42

9/5/96

23129320

APAP 325mg/codeine 60mg

38

9/18/96

23130077

APAP 325mg/codeine 60mg

35

10/1/96

23130815

APAP 325mg/codeine 30mg

42

10/15/96

23131560

APAP 325mg/codeine 60mg

32

10/29/96

23132295

APAP 325mg/codeine 60mg

29

11/12/96

23132990

APAP 325mg/codeine 60mg

26

11/26/96

23133555

APAP 325mg/codeine 60mg

25

12/9/96

23134374

APAP 325mg/codeine 60mg

23

12/24/96

23134944

APAP 325mg/codeine 60mg

23

1/7/97

300170

APAP 325mg/codeine 60mg

23

1/21/97

300170

APAP 325mg/codeine 60mg

23

2/4/97

301423

APAP 325mg/codeine 60mg

23

2/14/97

301423

APAP 325mg/codeine 60mg

23

3/3/97

302874

APAP 325mg/codeine 60mg

23

3/18/97

302874

APAP 325mg/codeine 60mg

23

3/31/97

303980

APAP 325mg/codeine 60mg

46

4/15/97

303980

APAP 325mg/codeine 60mg

46

5/12/97

306703

APAP 325mg/codeine 60mg

46

6/10/97

306703

APAP 325mg/codeine 60mg

46

7/2/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(52)   Suellen Ogden, as the Responsible Pharmacist did, from January 3, 1996, through June 25,1996, knowingly sell or offer to sell a controlled substance in an amount greater than three times the bulk amount, but in an amount less than one hundred times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #14 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23110472

hydrocodone 5mg/APAP 500mg

120

1/3/96

23116146

hydrocodone 5mg/APAP 500mg

120

1/20/96

23116146

hydrocodone 5mg/APAP 500mg

120

1/29/96

23116146

hydrocodone 5mg/APAP 500mg

120

2/7/96

23116146

hydrocodone 5mg/APAP 500mg

120

2/16/96

23116146

hydrocodone 5mg/APAP 500mg

120

2/26/96

23116146

hydrocodone 5mg/APAP 500mg

120

3/6/96

23119399

hydrocodone 5mg/APAP 500mg

120

3/16/96

23119399

hydrocodone 5mg/APAP 500mg

120

3/26/96

23119399

hydrocodone 5mg/APAP 500mg

120

4/9/96

23119399

hydrocodone 5mg/APAP 500mg

120

4/19/96

23119399

hydrocodone 5mg/APAP 500mg

120

4/30/96

23119399

hydrocodone 5mg/APAP 500mg

120

5/10/96

23123282

hydrocodone 5mg/APAP 500mg

120

5/24/96

23123282

hydrocodone 5mg/APAP 500mg

120

6/3/96

23123282

hydrocodone 5mg/APAP 500mg

120

6/12/96

23123282

hydrocodone 5mg/APAP 500mg

120

6/25/96

 

Such conduct is in violation of Section 2925.03(A)(7) (as was in effect during said time period) of the Ohio Revised Code.

 

(53)   Suellen Ogden, as the Responsible Pharmacist did, from July 10, 1996, through January 17, 1997, knowingly sell or offer to sell a controlled substance in an amount exceeding five times the bulk amount, but in an amount less than fifty times that amount when the conduct was not in accordance with Chapters 3719., 4729., and 4731. of the Ohio Revised Code, to wit: Suellen Ogden or a pharmacist under her control at Chesterfield Pharmacy sold the following controlled substances to Patient #14 without a legitimate medical purpose:

 

Rx No.

Drug

Quantity

Date

23123282

hydrocodone 5mg/APAP 500mg

120

7/10/96

23123282

hydrocodone 5mg/APAP 500mg

120

7/20/96

23127578

hydrocodone 5mg/APAP 500mg

120

8/12/96

23127578

hydrocodone 5mg/APAP 500mg

120

8/21/96

23127578

hydrocodone 5mg/APAP 500mg

120

8/30/96

23127578

hydrocodone 5mg/APAP 500mg

120

9/9/96

23127578

hydrocodone 5mg/APAP 500mg

120

9/18/96

23127578

hydrocodone 5mg/APAP 500mg

120

9/28/96

23132338

hydrocodone 5mg/APAP 500mg

120

11/12/96

23132338

hydrocodone 5mg/APAP 500mg

120

11/23/96

23132338

hydrocodone 5mg/APAP 500mg

120

12/5/96

23132338

hydrocodone 5mg/APAP 500mg

120

12/20/96

23132338

hydrocodone 5mg/APAP 500mg

120

1/2/97

23132338

hydrocodone 5mg/APAP 500mg

120

1/17/97

 

Such conduct is in violation of Section 2925.03(A) of the Ohio Revised Code.

 

(54)   Suellen Ogden did, on or about October 22, 1999, plead guilty to three counts of Illegal Processing of Drug Documents in violation of Section 2925.23 of the Ohio Revised Code, one a felony of the third degree, one a felony of the fourth degree, and one a felony of the fifth degree.State of Ohio vs. Suellen Ogden, Case No. CR 359485, Cuyahoga County Common Pleas Court.

 

(A)     The Summary Suspension Order issued by the Board is removed as of the effective date of this agreement.

 

(B)     A three-year suspension of Suellen Ogden's pharmacist identification card, No. 03‑1-20832, to be calculated from the effective date of the Summary Suspension of her license (November 23, 1999).

 

(1)     Suellen Ogden may be employed by or work in a facility licensed by the State Board of Pharmacy to possess or distribute dangerous drugs during such period of suspension, however her duties must be outside the confines of the barricaded pharmacy area. This term includes allowing Suellen Ogden to work as a pharmaceutical drug representative.

 

(2)     Division (B) of Section 4729.16 of the Revised Code provides that:"Any individual whose identification card is revoked, suspended, or refused, shall return the identification card and license [wall certificate] to the offices of the state board of pharmacy within ten days after receipt of notice of such action."The certificate and identification card should be forwarded by certified mail, return receipt requested.

 

(C)     Suellen Ogden must take and successfully complete the Jurisprudence examination offered by the Board prior to reinstatement and, if Suellen Ogden has not successfully completed the Jurisprudence examination prior to November 23, 2002, her license will remain suspended until this condition has been achieved.

 

(D)     Suellen Ogden's license, upon the completion of the terms of suspension and after having passed the Jurisprudence examination, will be issued automatically upon renewal which will require submission of continuing pharmacy education as set forth in Chapter 4729-7 of the Ohio Administrative Code.

 

(E)      Upon reinstatement, Suellen Ogden's pharmacist identification card, No. 03-1-20832, will be placed on probation for five years.The terms of probation are as follows:

 

(1)     The State Board of Pharmacy hereby declares that Suellen Ogden's pharmacist identification card is not in good standing and thereby denies the privilege of being a preceptor and training pharmacy interns pursuant to paragraph (D)(1) of Rule 4729-3-01 of the Ohio Administrative Code.

 

(2)     Suellen Ogden may not serve as a responsible pharmacist.

 

(3)     Suellen Ogden must not violate the drug laws of the state of Ohio, any other state, or the federal government.

 

(4)     Suellen Ogden must abide by the rules of the State Board of Pharmacy.

 

(5)     Suellen Ogden must comply with the terms of this agreement.

 

(F)      If, in the judgment of the Board, Suellen Ogden appears to have violated or breached any terms or conditions of this agreement, the State Board of Pharmacy reserves the right to, at any time, revoke probation, modify the conditions of probation, and reduce or extend the period of probation, and/or the Board may institute formal disciplinary proceedings for any and all possible violations or breaches, including but not limited to, alleged violation of the laws of Ohio occurring before the effective date of this agreement.

 

 

RES. 2000-156   Further, Mr. Winsley announced that John H. Lafferty, R.Ph. and Imogene Carol Maynard, R.Ph. refused to sign their Settlement Agreements, but since they signed the following Memorandum of Agreement, the Settlement Agreements became effective April 3, 2000:

 

MEMORANDUM OF AGREEMENT

 

The following terms of settlement have been reached by the parties, the Ohio State Board of Pharmacy and Respondents Ogden, Maynard, and Lafferty:

 

Ogden:

 

   Three year suspension, begin dated as of the date of the summary suspension;

   five years probation to commence after the term of suspension, terms include: cannot be responsible pharmacist and cannot be a preceptor;

   must take and pass the Ohio jurisprudence examination prior to reinstatement;

   may work in a facility licensed by the Board but job duties must be outside the confines of the barricaded pharmacy area; this term includes allowing Respondent to work as a pharmaceutical drug representative.

 

Maynard:

 

   one year suspension;

   two years probation to commence after the term of suspension, terms include: cannot be responsible pharmacist and cannot be a preceptor;

   must take and pass the Ohio jurisprudence examination prior to reinstatement;

   may work in a facility licensed by the Board but job duties must be outside the confines of the barricaded pharmacy area; this term includes allowing Respondent to work as a pharmaceutical drug representative.

 

Lafferty:

 

   one year suspension;

   two years probation to commence after the term of suspension, terms include: cannot be responsible pharmacist and cannot be a preceptor;

   must take and pass the Ohio jurisprudence examination prior to reinstatement;

   may work in a facility licensed by the Board but job duties must be outside the confines of the barricaded pharmacy area; this term includes allowing Respondent to work as a pharmaceutical drug representative.

 

For all respondents, upon the completion of the terms of suspension, and having passed the jurisprudence examination, the licenses will be issued automatically upon renewal, which may require submission of continuing pharmacy education data.

 

Dated  /d/     February 21, 2000     ;As agreed:

 

 /s/     W T Winsley                                            

Executive Director, Ohio State Board of Pharmacy

 

 /s/     Imogene C Maynard                                

Respondent

 

 /s/     David W. Grauer                                     

Attorney

 

 /s/     Suellen Ogden                                        

Respondent

 

 /s/     Bruce A. Zaccagnini                                

Attorney

 

 /s/     John H. Lafferty                                      

Respondent

 

 /s/     Spiros E. Gonakis                                   

Attorney